Related Experiment Videos
Transcutaneous immunization: T cell responses and boosting of existing immunity
S A Hammond1, D Walwender, C R Alving
1Walter Reed Army Institute of Research, Department of Membrane Biochemistry, Silver Spring, MD 20910-7500, USA. shammond@iomai.com
Vaccine
|March 21, 2001
Summary
Transcutaneous immunization (TCI) effectively induces T cell responses. Booster immunizations via TCI can enhance existing immunity, particularly when antibody levels are low, showing promise for vaccine development.
Area of Science:
- Immunology
- Vaccinology
Background:
- Transcutaneous immunization (TCI) is an emerging strategy for topical antigen and adjuvant delivery to intact skin.
- This method aims to elicit robust antibody and cell-mediated immune responses.
Purpose of the Study:
- To evaluate T cell responses following TCI using tetanus toxoid and various adjuvants.
- To investigate the efficacy of TCI as a boosting immunization strategy after intramuscular priming.
Main Methods:
- Tetanus toxoid was used as a model antigen for topical immunization on hydrated skin.
- T cell responses were analyzed after TCI with different adjuvants.
- The study assessed secondary immune responses after TCI boosting in previously primed individuals.
Main Results:
- TCI induced systemic antigen-specific T cell responses with a Th2 bias.
- TCI could augment existing immunity, with potent responses observed when antibody titers were low at boosting.
- The findings suggest TCI adheres to established immunological principles for vaccine delivery.
Conclusions:
- Transcutaneous immunization is a viable method for inducing systemic T cell immunity.
- TCI shows potential as a boosting strategy, particularly in scenarios of low pre-existing immunity.
- Further development of TCI, using tetanus toxoid as a model, could advance vaccine patch technology and product feasibility.